Stouten Pharma Consultancy SRL
Stouten Pharma Consultancy reported total assets of 242,184 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Aug 2026).
The score of Stouten Pharma Consultancy shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +708 % Total assets +562 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Stouten Pharma Consultancy's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Aug 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
Stouten Pharma Consultancy's financial analysis
- Solvency71.6%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Stouten Pharma Consultancy
Stouten Pharma Consultancy's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0800.893.564
- VAT number
- BE0800893564
- Peppol
- Registered · 0208:0800893564 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Apr 2023
- Registered office
- 2860 Sint-Katelijne-Waver
- Latest accounts
- 2025 · filed on 17 Aug 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Stouten Pharma Consultancy (SRL) has been based in Sint-Katelijne-Waver since 2023, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 57,915 € and equity of 173,437 €; its revenue is not published. Its solvency stands at 71.6%, above the median of its sector (55.4%).
Companies similar to Stouten Pharma Consultancy
Companies in the same business, of comparable size and area, outside its group.
- Niel Dejonghe Other information service activities Lubbeek · balance sheet 167,231 €
- Lavoordeleen Other information service activities Wingene · balance sheet €8.49m
- Algemeen Advies IN Milieuzorg EN Omgevingsvergunning Other information service activities Brasschaat · balance sheet 260,651 €
- IZI Fusion Other information service activities Forest · balance sheet 170,169 €
- Perpendiculum Other information technology and computer service activities Roosdaal · balance sheet 350,179 €
- Healthy IT Consulting Other information technology and computer service activities Londerzeel · balance sheet 213,803 €
- VDB-LabAdvise Other information service activities Herzele · balance sheet 379,287 €
- Apora.BE Other business support service activities n.e.c. Forest · balance sheet 613 €
Frequently asked questions about Stouten Pharma Consultancy
What is the revenue of Stouten Pharma Consultancy?
Stouten Pharma Consultancy files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Stouten Pharma Consultancy?
In Belgium, the VAT number is the company number prefixed with BE: BE0800893564 for Stouten Pharma Consultancy, if the company is VAT-registered. Its company number (CBE) is 0800.893.564.
Where is the registered office of Stouten Pharma Consultancy?
According to the CBE register, the registered office of Stouten Pharma Consultancy is in 2860 Sint-Katelijne-Waver.
What is the equity of Stouten Pharma Consultancy?
At the close of the 2025 financial year, the equity of Stouten Pharma Consultancy amounts to 173,437 €, a solvency of 71.6% of total assets.
Who manages Stouten Pharma Consultancy?
The register lists 1 active mandates at Stouten Pharma Consultancy. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Stouten Pharma Consultancy
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →